tirzepatide cause kidney stones improves outcomes in T2DM with increased CV risk Glp 1 And Kidney Stones:

Thank you, Freese & Goss! Rose A

Because semaglutide slows stomach emptying, residual food in the stomach increases aspiration risk under anaesthesia

Daley and colleagues revealed that hyperglycemia triggers Akt2 activation (phosphorylation) in RPE cells, which in turn increases the expression of EMT markers and fibrosis-related proteins via ERK signaling [6]

The semaglutide API segment is projected to grow at 16.2% CAGR through 2034, compared to an estimated 11.5% CAGR for the broader GLP-1 API market excluding semaglutide, as semaglutide gains additional market share from older GLP-1 agents and potentially from tirzepatide in indications where semaglutide maintains formulary advantages

Some products list both for clarity